These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29016844)

  • 21. Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo.
    Pu P; Kang C; Zhang Z; Liu X; Jiang H
    Technol Cancer Res Treat; 2006 Jun; 5(3):271-80. PubMed ID: 16700623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Significance and Mechanism of PI3K p110β Overexpression
 in Non-small Cell Lung Cancer].
    Xiong Y; Qu L; Li D; Wang Y; Li T
    Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):808-816. PubMed ID: 29277178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models.
    Jones NM; Rowe MR; Shepherd PR; McConnell MJ
    Int J Oncol; 2016 Jul; 49(1):207-16. PubMed ID: 27176780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of TGFβ1 in the expression of phosphoinositide 3-kinase isoform genes and sensitivity and response of lung telocytes to PI3K inhibitors.
    Song D; Tang L; Wang L; Huang J; Zeng T; Fang H; Wang X
    Cell Biol Toxicol; 2020 Feb; 36(1):51-64. PubMed ID: 31522336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connexin 43 confers chemoresistance through activating PI3K.
    Pridham KJ; Shah F; Hutchings KR; Sheng KL; Guo S; Liu M; Kanabur P; Lamouille S; Lewis G; Morales M; Jourdan J; Grek CL; Ghatnekar GG; Varghese R; Kelly DF; Gourdie RG; Sheng Z
    Oncogenesis; 2022 Jan; 11(1):2. PubMed ID: 35022385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
    Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
    Zhao JJ; Liu Z; Wang L; Shin E; Loda MF; Roberts TM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18443-8. PubMed ID: 16339315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
    Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct epithelial-to-mesenchymal transitions induced by
    Gjelaj E; Hamel PA
    J Cell Sci; 2021 Feb; 134(4):. PubMed ID: 33526718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.
    Cui W; Cai Y; Wang W; Liu Z; Wei P; Bi R; Chen W; Sun M; Zhou X
    J Transl Med; 2014 Jan; 12():10. PubMed ID: 24418330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Phosphoinositide 3-Kinase p110α and p110β Subunits and PIK3CA Mutation in Patients With Advanced Gastric Carcinoma.
    Kim K; Lee HW
    Appl Immunohistochem Mol Morphol; 2018; 26(10):740-748. PubMed ID: 28549032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
    Crowder RJ; Phommaly C; Tao Y; Hoog J; Luo J; Perou CM; Parker JS; Miller MA; Huntsman DG; Lin L; Snider J; Davies SR; Olson JA; Watson MA; Saporita A; Weber JD; Ellis MJ
    Cancer Res; 2009 May; 69(9):3955-62. PubMed ID: 19366795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
    Harding JJ; Bauer TM; Tan DSW; Bedard PL; Rodon J; Doi T; Schnell C; Iyer V; Baffert F; Radhakrishnan R; Fabre C; Juric D
    Invest New Drugs; 2019 Apr; 37(2):271-281. PubMed ID: 30073466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of GFP-Fusion p110α and p110β Isoforms of PI3K Signaling Pathway in Normal and Cancer Cells.
    Singh P; Dar MS; Singh G; Jamwal G; Sharma PR; Ahmad M; Dar MJ
    J Cell Biochem; 2016 Dec; 117(12):2864-2874. PubMed ID: 27167447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.
    Berenjeno IM; Guillermet-Guibert J; Pearce W; Gray A; Fleming S; Vanhaesebroeck B
    Biochem J; 2012 Feb; 442(1):151-9. PubMed ID: 22150431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
    Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
    CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.
    Edgar KA; Wallin JJ; Berry M; Lee LB; Prior WW; Sampath D; Friedman LS; Belvin M
    Cancer Res; 2010 Feb; 70(3):1164-72. PubMed ID: 20103642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
    Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
    J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.
    Tran AN; Walker K; Harrison DG; Chen W; Mobley J; Hocevar L; Hackney JR; Sedaka RS; Pollock JS; Goldberg MS; Hambardzumyan D; Cooper SJ; Gillespie Y; Hjelmeland AB
    Neuro Oncol; 2018 Jul; 20(8):1055-1067. PubMed ID: 29409010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
    Khanna A; Thoms JAI; Stringer BW; Chung SA; Ensbey KS; Jue TR; Jahan Z; Subramanian S; Anande G; Shen H; Unnikrishnan A; McDonald KL; Day BW; Pimanda JE
    Mol Cancer Res; 2020 May; 18(5):709-722. PubMed ID: 32079743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.